NSCLC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
NSCLC
May 8, 2024, 00:58 |
Blog
Stephen V Liu: Dr. Passiglia Fra at Rome Lung 24 illustrates the limited role of immunotherapy in driver positive NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 8, 2024, 00:50 |
Blog
Stephen V Liu: Dr. Giulia Pasello at Rome Lung 24 discusses duration of immunotherapy for NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 6, 2024, 19:10 |
Blog
Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations
Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X: "Metastatic NSCLC without oncogenic…
May 6, 2024, 12:58 |
Blog
Iván R. González: The NEOpredict-Lung study represents an importantevolution in the treatment of resectable NSCLC
Iván R. González, Medical Oncologist at Comprehensive Oncology Center, Hospital Ángeles Puebla, shared a post…
May 3, 2024, 15:47 |
Blog
Percy Lee: ACCC webinar on advances in management of early stage NSCLC
Percy Lee, Professor and Section Chief of the Thoracic Radiation Oncology at The University of Texas…
May 3, 2024, 04:28 |
Blog
Erman Akkus: Roundup of the last year-Practice changing trials in NSCLC
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X/Twitter: "Roundup…
May 2, 2024, 15:25 |
Blog
Tanja Obradovic: Interesting updates will be coming on ASCO 2024
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: "ASCO 2024 is almost…
May 2, 2024, 14:30 |
Societies
Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC - ASCO
American Society of Clinical Oncology (ASCO) shared on X: “Breaking news from the ASCO Plenary Series:…
May 2, 2024, 14:14 |
Blog
Stephen V Liu discusses KRAS mutant NSCLC with Veluswamy and Mariana Brandao - IASLC
International Association for the Study of Lung Cancer (IASLC) shared on X: “KRAS mutations are…
May 1, 2024, 09:08 |
Insight
Piotr Wysocki: Adjuvant immunotherapy in NSCLC patients who underwent radical resection preceded by immunotherapy
Piotr Wysocki recently shared on LinkedIn: "Zhou Y et al. have conducted an indirect meta-analysis…
1
2
3
4
5
All:
105
Posts:
1 - 10
Neuroendocrine tumors - newly updated AJCC guidelines
5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari
OncoInfluencers: Dialogue with Tony Mok, hosted by Gevorg Tamamyan
New Paper Alert! Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma
Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Facebook
RSS Feed
Twitter
Linkedin
Youtube